Creative Financial Designs Inc Amgen Inc Transaction History

Creative Financial Designs Inc

$1.16 Billion
Q3 2024

A detailed history of Creative Financial Designs Inc transactions in Amgen Inc stock. As of the latest transaction made, Creative Financial Designs Inc holds 5,149 shares of AMGN stock, worth $1.36 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,149

Previous 5,181 0.62%

Holding current value

$1.36 Million

Previous $1.62 Million 2.53%

% of portfolio

0.14%

Previous 0.15%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $9,900 - $10,796	-32 Reduced 0.62%	5,149 $1.66 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $10,772 - $13,091	41 Added 0.8%	5,181 $1.62 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $126,100 - $152,218	-469 Reduced 8.36%	5,140 $1.46 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $23,013 - $25,961	-90 Reduced 1.58%	5,609 $1.62 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $26,456 - $32,846	-121 Reduced 2.08%	5,699 $1.53 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $49,067 - $58,021	229 Added 4.1%	5,820 $1.29 Million
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $61,640 - $75,129	273 Added 5.13%	5,591 $1.35 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $26,567 - $33,757	116 Added 2.23%	5,318 $1.4 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $137,145 - $154,674	611 Added 13.31%	5,202 $1.17 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $30,684 - $34,146	133 Added 2.98%	4,591 $1.12 Million
Q1 2022 Apr 15, 2022	BUY	$219.27 - $242.57 $57,010 - $63,068	260 Added 6.19%	4,458 $1.08 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $21,876 - $25,036	110 Added 2.69%	4,198 $944,000
Q3 2021 Oct 08, 2021	BUY	$212.27 - $248.7 $384,208 - $450,147	1,810 Added 79.46%	4,088 $869,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $56,526 - $62,711	242 Added 11.89%	2,278 $555,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $63,466 - $73,959	-286 Reduced 12.32%	2,036 $506,000
Q4 2020 Jan 08, 2021	BUY	$216.38 - $257.67 $439,684 - $523,585	2,032 Added 700.69%	2,322 $534,000
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $66,405 - $73,848	283 Added 4042.86%	290 $74,000
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $1,384 - $1,699	7 New	7 $2,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $56,858 - $75,410	-312 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $1.79 Million - $2.3 Million	-9,454 Reduced 96.81%	312 $75,000
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $59,893 - $71,765	-344 Reduced 3.4%	9,766 $1.85 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $171,534 - $201,076	1,029 Added 11.33%	10,110 $1.84 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $1.83 Million - $2.06 Million	-10,106 Reduced 52.67%	9,081 $1.73 Million
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $54,947 - $64,141	-308 Reduced 1.58%	19,187 $3.74 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $2,408 - $2,715	-13 Reduced 0.07%	19,495 $4.04 Million
Q2 2018 Jul 13, 2018	BUY	$166.05 - $186.51 $25,571 - $28,722	154 Added 0.8%	19,508 $3.6 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $42,526 - $49,698	-251 Reduced 1.28%	19,354 $3.3 Million
Q4 2017 May 02, 2018	SELL	$168.79 - $188.59 $284,411 - $317,774	-1,685 Reduced 7.91%	19,605 $3.41 Million
Q3 2017 May 02, 2018	SELL	$167.29 - $191.0 $123,794 - $141,340	-740 Reduced 3.36%	21,290 $3.97 Million
Q2 2017 May 02, 2018	SELL	N/A	-344 Reduced 1.54%	22,030 $3.79 Million
Q1 2017 May 02, 2018	BUY	N/A	849 Added 3.94%	22,374 $3.67 Million
Q4 2016 Mar 14, 2018	BUY	N/A	21,525	21,525 $3.15 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Account

Creative Financial Designs Inc Amgen Inc Transaction History